Minimizing bias in target selection by exploiting multidisciplinary Big Data and the protein interactome
Available to view on demand. You'll learn how to use canSAR to enhance selection of new cancer drug targets - currently a major focus area to reduce attrition in the clinic.
Please sign in or register for FREE to view this content
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.